Denmark· DK-28106447320

Zenalpha

A qn05cm99 product containing medetomidinhydrochlorid, vatinoxanhydrochlorid, registered in Denmark by Vetcare Oy.

ATC QN05CM99

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedZenalphaATCQN05CM99REGISTER NO.DK-28106447320PACKS LISTED1CHECKEDSeptember 30, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Medetomidinhydrochlorid, Vatinoxanhydrochlorid
Manufacturer
Vetcare Oy
Country
Denmark (DK)
ATC code
QN05CM99
ATC class
QN05CM99
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106447320

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6be36f8c-fa62-458f-a3ca-6aab15db0a4c
GET /v1/drugs/6be36f8c-fa62-458f-a3ca-6aab15db0a4c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "injektionsvæske, opløsning",
  "source": "dkma",
  "strength": "0,5+10 mg/ml",
  "auth_role": "CO-RAP",
  "dk_drugid": "28106447320",
  "substance": "Medetomidinhydrochlorid, Vatinoxanhydrochlorid",
  "auth_procedure": "Central",
  "in_medicinpriser": true,
  "registration_date_serial": "44545"
}

See everything about medetomidinhydrochlorid, vatinoxanhydrochlorid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.